Domov › BOPC › Texas › Houston

Klinične študije za BOPC v Houston, TX

15 študij za BOPC išče udeležence na lokacijah v Houston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Vključevanje udeležencevFaza 3

Research Site, Houston
Research Site, Houston
Research Site, Houston

Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Vključevanje udeležencevFaza 3

Se Houston- Site Number : 8400120, Houston
Aavon Clinical Trials, Llc- Site Number : 8400166, Houston

Starost 40–80 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07190222

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Vključevanje udeležencevFaza 2

Baylor College of Medicine Medical Center, Houston

Starost 40–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Vključevanje udeležencevFaza 3

Trio Clinical Trials- Site Number : 8400106, Houston
HDH Research- Site Number : 8400104, Houston
Baylor College of Medicine- Site Number : 8400076, Houston
in še 2

Starost 40–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Vključevanje udeležencevFaza 2

Research Site, Houston

Starost 40 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Vključevanje udeležencevFaza 2

Baylor College of Medicine, Houston

Starost 40 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Vključevanje udeležencevFaza 3

Research Site, Houston
Research Site, Houston
Research Site, Houston

Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Vključevanje udeležencevFaza 3

Research Site, Houston
Research Site, Houston
Research Site, Humble · 17 mi stran

Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Vključevanje udeležencevFaza 2/3

Greater Heights & Memorial Pulmonary and Sleep, Houston
Houston Pulmonary Sleep and Allergy Associates, Houston

Starost 35–80 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07363694

STRIVE Post-Market Registry Study

Vključevanje udeležencevOpazovalna študija

University of Texas Health Science Center at Houston, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Vključevanje udeležencevFaza 3

GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Houston

Starost 40–75 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07177339

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Vključevanje udeležencev

Houston Methodist/Primary Critical Care, Houston

Starost 40–84 · Vsi spoli · Posodobljeno 24. apr. 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Vključevanje udeležencevFaza 3

GSK Investigational Site, Houston

Starost 40–80 · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT06961214

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Vključevanje udeležencevOpazovalna študija

Horizon Clinical Research Group, Houston

Starost 50 in več · Vsi spoli · Posodobljeno 5. avg. 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Vključevanje udeležencev

Respire Research Institute, Houston

Starost 30 in več · Vsi spoli · Posodobljeno 6. feb. 2025 · NCT05204888

Študije za BOPC v drugih mestih

Druge študije v Houston

Vir: ClinicalTrials.gov, podatki pridobljeni 4. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.